img

Global Metabotropic Glutamate Receptor 5 Market Opportunities and Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 450 | Industry : Pharma & Healthcare

Publisher : GRD Survery | Format : PDF

Global Metabotropic Glutamate Receptor 5 Market Opportunities and Forecast 2024-2034

This report provides a comprehensive analysis of current global Metabotropic Glutamate Receptor 5 market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Metabotropic Glutamate Receptor 5 industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Metabotropic Glutamate Receptor 5 market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Metabotropic Glutamate Receptor 5 Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Metabotropic Glutamate Receptor 5 market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Metabotropic Glutamate Receptor 5 Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Metabotropic Glutamate Receptor 5 industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions


Segmented by Type
Alloswitch-1
BMS-952048

Segmented by Application
Major Depressive Disorder
Alcohol Addiction
Alzheimer's Disease
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Richter Gedeon Nyrt
Novartis AG
Merz Pharma GmbH & Co KgaA
Johnson & Johnson
Heptares Therapeutics Ltd
Eli Lilly and Company
Eisai Co Ltd
Bristol-Myers Squibb Company
Aevi Genomic Medicine Inc
Addex Therapeutics Ltd


Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Metabotropic Glutamate Receptor 5 Market Status and Forecast (2016-2027)
1.3.2 Global Metabotropic Glutamate Receptor 5 Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Metabotropic Glutamate Receptor 5 Supply by Company
2.1 Global Metabotropic Glutamate Receptor 5 Sales Volume by Company
2.2 Global Metabotropic Glutamate Receptor 5 Sales Value by Company
2.3 Global Metabotropic Glutamate Receptor 5 Price by Company
2.4 Metabotropic Glutamate Receptor 5 Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Metabotropic Glutamate Receptor 5 Market Status by Type
3.1 Metabotropic Glutamate Receptor 5 Type Introduction
3.1.1 Alloswitch-1
3.1.2 BMS-952048
3.1.3 BMS-955829
3.1.4 Dipraglurant ER
3.1.5 Others
3.2 Global Metabotropic Glutamate Receptor 5 Market by Type
3.2.1 Global Metabotropic Glutamate Receptor 5 Sales Volume by Type (2016-2021)
3.2.2 Global Metabotropic Glutamate Receptor 5 Sales Value by Type (2016-2021)
3.2.3 Global Metabotropic Glutamate Receptor 5 Price by Type (2016-2021)
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Metabotropic Glutamate Receptor 5 Market Status by Application
4.1 Metabotropic Glutamate Receptor 5 Segment by Application
4.1.1 Major Depressive Disorder
4.1.2 Alcohol Addiction
4.1.3 Alzheimer's Disease
4.1.4 Others
4.2 Global Metabotropic Glutamate Receptor 5 Market by Application
4.2.1 Global Metabotropic Glutamate Receptor 5 Sales Volume by Application (2016-2021)
4.2.2 Global Metabotropic Glutamate Receptor 5 Sales Value by Application (2016-2021)
4.2.3 Global Metabotropic Glutamate Receptor 5 Price by Application (2016-2021)
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Metabotropic Glutamate Receptor 5 Market Status by Region
5.1 Global Metabotropic Glutamate Receptor 5 Market by Region
5.1.1 Global Metabotropic Glutamate Receptor 5 Sales Volume by Region
5.1.2 Global Metabotropic Glutamate Receptor 5 Sales Value by Region
5.2 North America Metabotropic Glutamate Receptor 5 Market Status
5.3 Europe Metabotropic Glutamate Receptor 5 Market Status
5.4 Asia Pacific Metabotropic Glutamate Receptor 5 Market Status
5.5 Central & South America Metabotropic Glutamate Receptor 5 Market Status
5.6 Middle East & Africa Metabotropic Glutamate Receptor 5 Market Status
6 North America Metabotropic Glutamate Receptor 5 Market Status
6.1 North America Metabotropic Glutamate Receptor 5 Market by Country
6.1.1 North America Metabotropic Glutamate Receptor 5 Sales Volume by Country (2016-2021)
6.1.2 North America Metabotropic Glutamate Receptor 5 Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Metabotropic Glutamate Receptor 5 Market Status
7.1 Europe Metabotropic Glutamate Receptor 5 Market by Country
7.1.1 Europe Metabotropic Glutamate Receptor 5 Sales Volume by Country (2016-2021)
7.1.2 Europe Metabotropic Glutamate Receptor 5 Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Metabotropic Glutamate Receptor 5 Market Status
8.1 Asia Pacific Metabotropic Glutamate Receptor 5 Market by Country
8.1.1 Asia Pacific Metabotropic Glutamate Receptor 5 Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Metabotropic Glutamate Receptor 5 Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Metabotropic Glutamate Receptor 5 Market Status
9.1 Central & South America Metabotropic Glutamate Receptor 5 Market by Country
9.1.1 Central & South America Metabotropic Glutamate Receptor 5 Sales Volume by Country (2016-2021)
9.1.2 Central & South America Metabotropic Glutamate Receptor 5 Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Metabotropic Glutamate Receptor 5 Market Status
10.1 Middle East & Africa Metabotropic Glutamate Receptor 5 Market by Country
10.1.1 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Metabotropic Glutamate Receptor 5 Manufacturing Cost Analysis
11.5 Metabotropic Glutamate Receptor 5 Sales Channel and Distributors Analysis
11.5.1 Metabotropic Glutamate Receptor 5 Sales Channel
11.5.2 Metabotropic Glutamate Receptor 5 Distributors
11.6 Metabotropic Glutamate Receptor 5 Downstream Major Buyers
12 Global Metabotropic Glutamate Receptor 5 Market Forecast by Type and by Application
12.1 Global Metabotropic Glutamate Receptor 5 Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Metabotropic Glutamate Receptor 5 Forecast by Type
12.2.1 Global Metabotropic Glutamate Receptor 5 Sales Volume Forecast by Type
12.2.2 Global Metabotropic Glutamate Receptor 5 Sales Value Forecast by Type
12.2.3 Global Metabotropic Glutamate Receptor 5 Price Forecast by Type
12.3 Global Metabotropic Glutamate Receptor 5 Forecast by Application
12.3.1 Global Metabotropic Glutamate Receptor 5 Sales Volume Forecast by Application
12.3.2 Global Metabotropic Glutamate Receptor 5 Sales Value Forecast by Application
12.3.3 Global Metabotropic Glutamate Receptor 5 Price Forecast by Application
13 Global Metabotropic Glutamate Receptor 5 Market Forecast by Region/Country
13.1 Global Metabotropic Glutamate Receptor 5 Market Forecast by Region (2022-2027)
13.1.1 Global Metabotropic Glutamate Receptor 5 Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Metabotropic Glutamate Receptor 5 Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Toray Industries Inc
14.1.1 Company Information
14.1.2 Metabotropic Glutamate Receptor 5 Product Introduction
14.1.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
14.2 Sumitomo Dainippon Pharma Co Ltd
14.2.1 Company Information
14.2.2 Metabotropic Glutamate Receptor 5 Product Introduction
14.2.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.2.4 SWOT Analysis
14.3 Richter Gedeon Nyrt
14.3.1 Company Information
14.3.2 Metabotropic Glutamate Receptor 5 Product Introduction
14.3.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.3.4 SWOT Analysis
14.4 Novartis AG
14.4.1 Company Information
14.4.2 Metabotropic Glutamate Receptor 5 Product Introduction
14.4.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.4.4 SWOT Analysis
14.5 Merz Pharma GmbH & Co KgaA
14.5.1 Company Information
14.5.2 Metabotropic Glutamate Receptor 5 Product Introduction
14.5.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.5.4 SWOT Analysis
14.6 Johnson & Johnson
14.6.1 Company Information
14.6.2 Metabotropic Glutamate Receptor 5 Product Introduction
14.6.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.6.4 SWOT Analysis
14.7 Heptares Therapeutics Ltd
14.7.1 Company Information
14.7.2 Metabotropic Glutamate Receptor 5 Product Introduction
14.7.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.7.4 SWOT Analysis
14.8 Eli Lilly and Company
14.8.1 Company Information
14.8.2 Metabotropic Glutamate Receptor 5 Product Introduction
14.8.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.8.4 SWOT Analysis
14.9 Eisai Co Ltd
14.9.1 Company Information
14.9.2 Metabotropic Glutamate Receptor 5 Product Introduction
14.9.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.9.4 SWOT Analysis
14.10 Bristol-Myers Squibb Company
14.10.1 Company Information
14.10.2 Metabotropic Glutamate Receptor 5 Product Introduction
14.10.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.10.4 SWOT Analysis
14.11 Aevi Genomic Medicine Inc
14.12 Addex Therapeutics Ltd
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Metabotropic Glutamate Receptor 5 Sales Value and CAGR by Region (2016-2027)
Table Global Metabotropic Glutamate Receptor 5 Sales Volume by Company (2019-2021)
Table Global Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Company (2019-2021)
Table Global Metabotropic Glutamate Receptor 5 Sales Value by Company (2019-2021)
Table Global Metabotropic Glutamate Receptor 5 Sales Value and CAGR by Region (2016-2027)
Table Global Metabotropic Glutamate Receptor 5 Price by Company (2019-2021)
Table Main Manufacturers Metabotropic Glutamate Receptor 5 Product Location and Sales Area
Table Global Metabotropic Glutamate Receptor 5 Sales Value by Company (2019-2021)
Table Global Metabotropic Glutamate Receptor 5 Sales Volume by Type (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Type (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Sales Value by Type (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Sals Value Market Share by Type (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Price by Type (2016-2021)
Table North America Metabotropic Glutamate Receptor 5 Sales Volume by Type (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Sales Value by Type (2016-2021)
Table Europe Metabotropic Glutamate Receptor 5 Sales Volume by Type (2016-2021)
Table Europe Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Type (2016-2021)
Table Asia Pacific Metabotropic Glutamate Receptor 5 Sales Volume by Type (2016-2021)
Table Asia Pacific Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Type (2016-2021)
Table Central & South America Metabotropic Glutamate Receptor 5 Sales Volume by Type (2016-2021)
Table Central & South America Pacific Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Type (2016-2021)
Table Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Volume by Type (2016-2021)
Table Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Type (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Sales Volume by Application (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Application (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Sales Value by Application (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Value Market Share by Application (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Price by Application (2016-2021)
Table North America Metabotropic Glutamate Receptor 5 Sales Volume by Application (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Sales Value by Application (2016-2021)
Table Europe Metabotropic Glutamate Receptor 5 Sales Volume by Application (2016-2021)
Table Europe Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Application (2016-2021)
Table Asia Pacific Metabotropic Glutamate Receptor 5 Sales Volume by Application (2016-2021)
Table Asia Pacific Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Application (2016-2021)
Table Central & South America Metabotropic Glutamate Receptor 5 Sales Volume by Application (2016-2021)
Table Central & South America Pacific Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Application (2016-2021)
Table Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Volume by Application (2016-2021)
Table Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Application (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Sales Volume by Region (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Region (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Sales Value by Region (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Value Market Share by Region (2016-2021)
Table North America Metabotropic Glutamate Receptor 5 Sales Volume by Country (2016-2021)
Table North America Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Country (2016-2021)
Table Global Metabotropic Glutamate Receptor 5 Sales Value by Region/Country (2016-2021)
Table North America Metabotropic Glutamate Receptor 5 Value Market Share by Country (2016-2021)
Table Europe Metabotropic Glutamate Receptor 5 Sales Volume by Country (2016-2021)
Table Europe Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Country (2016-2021)
Table Europe Metabotropic Glutamate Receptor 5 Sales Value by Country (2016-2021)
Table Europe Metabotropic Glutamate Receptor 5 Value Market Share by Country (2016-2021)
Table Asia Pacific Metabotropic Glutamate Receptor 5 Sales Volume by Country (2016-2021)
Table Asia Pacific Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Country (2016-2021)
Table Asia Pacific Metabotropic Glutamate Receptor 5 Sales Value by Country (2016-2021)
Table Asia Pacific Metabotropic Glutamate Receptor 5 Value Market Share by Country (2016-2021)
Table Central & South America Metabotropic Glutamate Receptor 5 Sales Volume by Country (2016-2021)
Table Central & South America Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Country (2016-2021)
Table Central & South America Metabotropic Glutamate Receptor 5 Sales Value by Country (2016-2021)
Table Central & South America Metabotropic Glutamate Receptor 5 Value Market Share by Country (2016-2021)
Table Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Volume by Country (2016-2021)
Table Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Country (2016-2021)
Table Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Value by Country (2016-2021)
Table Middle East & Africa Metabotropic Glutamate Receptor 5 Value Market Share by Country (2016-2021)
Table Metabotropic Glutamate Receptor 5 Raw Materials Key Suppliers List
Table Metabotropic Glutamate Receptor 5 Distributors List
Table Metabotropic Glutamate Receptor 5 Buyers List
Table Global Metabotropic Glutamate Receptor 5 Sales Volume Forecast by Type (2022-2027)
Table Global Metabotropic Glutamate Receptor 5 Sales Volume Market Share Forecast by Type (2022-2027)
Table Global Metabotropic Glutamate Receptor 5 Value Forecast by Type (2022-2027)
Table Global Metabotropic Glutamate Receptor 5 Value Market Share Forecast by Type (2022-2027)
Table Global Metabotropic Glutamate Receptor 5 Price Forecast by Type (2022-2027)
Table Global Metabotropic Glutamate Receptor 5 Sales Volume Forecast by Application (2022-2027)
Table Global Metabotropic Glutamate Receptor 5 Value Forecast by Type (2022-2027)
Table Global Metabotropic Glutamate Receptor 5 Value Forecast by Application (2022-2027)
Table Global Metabotropic Glutamate Receptor 5 Value Market Share Forecast by Application (2022-2027)
Table Global Metabotropic Glutamate Receptor 5 Price Forecast by Application (2022-2027)
Table Global Metabotropic Glutamate Receptor 5 Sales Volume Forecast by Region (2022-2027)
Table Global Metabotropic Glutamate Receptor 5 Value Forecast by Application (2022-2027)
Table Global Metabotropic Glutamate Receptor 5 Value Forecast by Region (2022-2027)
Table Global Metabotropic Glutamate Receptor 5 Value Market Share Forecast by Region (2022-2027)
Table Toray Industries Inc Company Information
Table Toray Industries Inc Product Introduction
Table Global Metabotropic Glutamate Receptor 5 Value Forecast by Region (2022-2027)
Table Sumitomo Dainippon Pharma Co Ltd Company Information
Table Sumitomo Dainippon Pharma Co Ltd Product Introduction
Table Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Richter Gedeon Nyrt Company Information
Table Richter Gedeon Nyrt Product Introduction
Table Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Novartis AG Company Information
Table Novartis AG Product Introduction
Table Novartis AG Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Merz Pharma GmbH & Co KgaA Company Information
Table Merz Pharma GmbH & Co KgaA Product Introduction
Table Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Johnson & Johnson Company Information
Table Johnson & Johnson Product Introduction
Table Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Heptares Therapeutics Ltd Company Information
Table Heptares Therapeutics Ltd Product Introduction
Table Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Eli Lilly and Company Company Information
Table Eli Lilly and Company Product Introduction
Table Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Eisai Co Ltd Company Information
Table Eisai Co Ltd Product Introduction
Table Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Bristol-Myers Squibb Company Company Information
Table Bristol-Myers Squibb Company Product Introduction
Table Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales Volume, Price, Sales Value and Gross Margin (2019-2021)